IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy
Expanded access is temporarily not available for this treatment.
Sponsor:
Shanghai Chest Hospital
Collaborators:
Guangdong General Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Information provided by:
Shanghai Chest Hospital
ClinicalTrials.gov Identifier:
NCT01297101
First received: February 15, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | Expanded access is temporarily not available for this treatment. |
|---|---|
| Study Completion Date: | No date given |
| Primary Completion Date: | No date given |